Teicoplanin-induced vasculitis with cutaneous and renal involvement.
We present a case of cutaneous vasculitis with renal impairment. This developed whilst receiving teicoplanin for Staphylococcus aureus osteomyelitis of the hip.
Logan
S A E
SA
Department of Infection and Tropical Medicine, Northwick Park Hospital, Harrow, Middlesex HA5 3UJ, UK.
Brown
M
M
Davidson
R N
RN
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D005076:Exanthema / Q000139:chemically induced; D006615:Hip / Q000382:microbiology; D006801:Humans; D008297:Male; D010019:Osteomyelitis / Q000188:drug therapy* / Q000382:microbiology; D051437:Renal Insufficiency / Q000139:chemically induced; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D017334:Teicoplanin / Q000009:adverse effects*; D014657:Vasculitis / Q000139:chemically induced*
D000900:Anti-Bacterial Agents; D017334:Teicoplanin